Alivus Life Sciences Corporate Filings & Announcements

Latest corporate announcements and filings from Alivus Life Sciences on BSE

Search Inside the pdf :

Alivus Life Sciences Ltd.

29 Apr 2026

1076.60

0.69%

Corp. Note

Alivus Life Sciences Ltd - 543322 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAlivus Life Sciences Ltd 2CIN NO.L74900PN2011PLC139963 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Rudalf Corriea Designation: Company Secretary and Compliance Officer EmailId: complianceofficer@alivus.com Name of the Chief Financial Officer: Tushar Mistry Designation: Chief Financial Officer EmailId: Tushar.Mistry@alivus.com Date: 29/04/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Alivus Life Sciences Ltd.

21 Mar 2026

1076.60

0.69%

Company Update

Alivus Life Sciences Ltd - 543322 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

BSE India

Kindly refer attachment.

pdf

Alivus Life Sciences Ltd.

12 Mar 2026

1076.60

0.69%

Company Update

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting

pdf